News

BioInvent INernational AB expands its manufacturing capability with 3, 50, 200 and 1000 liter bioreactors from Merck.

The new Pan-Dataset Density Analysis (PanDDA) method extracts the picture of the bound compound in exceptionally clear and unambiguous detail.

INTERVALS is a website and resources enabling high-quality sharing of toxicological data among the inhalation science community.

Scientists have created an innovative technique for studying how chlamydia invades our immune system, using a combination of gene editing and stem cells.

Two teams investigated whether an antisense oligonucleotide drug that turns off the ATXN2 gene could be used as a potential therapy in mouse models of these diseases.

A strategic agreement between Europe’s flagship laboratory for basic research in molecular biology and the world’s largest medicinal chemistry design house.

Researchers at Monash University solve structure of drug target for osteoperosis, diabetes and obesity.

Combining Metrion's electrophysiological expertise and screening capability with Venomtech's compound library and venom-based drug discovery expertise will rapidly exploit and develop novel tools for ion channel drug discovery research.

Study describes how a complete knockout of the Ngly1 gene in mice leads to death just before birth, which can be partially rescued by the second knockout of another gene called Engase.

Cutting out certain amino acids – the building blocks of proteins – from the diet of mice slows tumour growth and prolongs survival, according to new research published in Nature.